FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...

Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.

Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...

Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...

Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.

A study finds permissive lab screening thresholds double primary aldosteronism detection rates versus Endocrine Society ...

Hologic and Inpeco have partnered to connect Panther Systems with FlexLab X automation in Europe, aiming to improve ...

Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...

A study reports that liquid biopsy tests can detect early lung cancer recurrence months before imaging in NSCLC patients.

Biodesix, in partnership with Bio-Rad and Thermo Fisher Scientific, advances tumor-informed and tumor-naïve MRD assays for ...

Guardant Health and partners will present 25 abstracts on liquid biopsy advances for cancer monitoring at ESMO 2026.

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...